• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑郁门诊患者的焦虑痛苦:患病率、共病和增量效度。

Anxious distress in depressed outpatients: Prevalence, comorbidity, and incremental validity.

机构信息

Center for Anxiety and Related Disorders, Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.

Center for Anxiety and Related Disorders, Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.

出版信息

J Psychiatr Res. 2018 Aug;103:54-60. doi: 10.1016/j.jpsychires.2018.05.006. Epub 2018 May 8.

DOI:10.1016/j.jpsychires.2018.05.006
PMID:29778071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8903047/
Abstract

The goals of this study were to estimate the prevalence of the DSM-5 anxious distress specifier (AD) among depressed outpatients, to examine associations of AD with comorbid diagnoses, and to test the incremental validity of AD over comorbidity in predicting functional impairment and severity of anxiety and depression symptoms. The sample was 237 outpatients diagnosed with major depressive disorder (MDD) or persistent depressive disorder (PDD), with and without AD, using the Anxiety and Related Disorders Interview Schedule for DSM-5. Outpatients also completed self-report questionnaires assessing functional impairment and anxiety, stress, and depression symptom severity. Two-by-two contingency tables were used to examine the associations of AD with comorbidity. Two-thirds (66.2%) of outpatients were assigned AD, with similar rates among those with MDD and PDD. Outpatients with AD were significantly more likely than those without AD to have a comorbid GAD diagnosis (OR = 2.47). Hierarchical multiple regressions were used to test the incremental validity of AD in predicting functional impairment and symptom outcomes beyond comorbid disorders. Controlling for comorbid disorders, AD was significantly associated with more severe functional impairment, autonomic arousal, stress, panic, generalized anxiety, and depression. The strongest incremental association were observed between AD and autonomic arousal (f = 0.12-0.18) and generalized anxiety (f = 0.17). These findings add to a growing literature that AD is common among outpatients and associated with important clinical outcomes, suggesting that AD should be routinely assessed in patients with mood disorders.

摘要

本研究的目的是估算 DSM-5 焦虑困扰特征(AD)在抑郁门诊患者中的患病率,检验 AD 与合并诊断的关联,并检验 AD 对预测功能障碍以及焦虑和抑郁症状严重程度的补充有效性。使用焦虑及相关障碍访谈表 DSM-5 对 237 名被诊断为重度抑郁障碍(MDD)或持续性抑郁障碍(PDD)且存在或不存在 AD 的门诊患者进行样本采集。门诊患者还完成了评估功能障碍以及焦虑、压力和抑郁症状严重程度的自我报告问卷。使用二项式列联表检验 AD 与合并症的关联。三分之二(66.2%)的门诊患者被分配到 AD,其中 MDD 和 PDD 的比例相似。患有 AD 的门诊患者比没有 AD 的患者更有可能合并广泛性焦虑症诊断(OR=2.47)。使用分层多元回归检验 AD 在预测功能障碍和症状结局方面对合并症的补充有效性。在控制合并症的情况下,AD 与更严重的功能障碍、自主唤醒、压力、惊恐、广泛性焦虑和抑郁显著相关。AD 与自主唤醒(f=0.12-0.18)和广泛性焦虑(f=0.17)之间存在最强的增量关联。这些发现增加了越来越多的文献,即 AD 在门诊患者中很常见,并且与重要的临床结局相关,这表明在心境障碍患者中应常规评估 AD。

相似文献

1
Anxious distress in depressed outpatients: Prevalence, comorbidity, and incremental validity.抑郁门诊患者的焦虑痛苦:患病率、共病和增量效度。
J Psychiatr Res. 2018 Aug;103:54-60. doi: 10.1016/j.jpsychires.2018.05.006. Epub 2018 May 8.
2
Reliability and validity of the DSM-5 Anxious Distress Specifier Interview.《精神疾病诊断与统计手册》第五版焦虑痛苦特征访谈的信度与效度
Compr Psychiatry. 2017 Jul;76:11-17. doi: 10.1016/j.comppsych.2017.02.010. Epub 2017 Mar 2.
3
A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.一种针对重度抑郁症的DSM-5焦虑痛苦特征的具有临床实用性的自我报告测量方法。
J Clin Psychiatry. 2014 Jun;75(6):601-7. doi: 10.4088/JCP.13m08961.
4
Validity of the DSM-5 anxious distress specifier for major depressive disorder.DSM-5 焦虑痛苦特征对重性抑郁障碍的有效性。
Depress Anxiety. 2019 Jan;36(1):31-38. doi: 10.1002/da.22837. Epub 2018 Oct 12.
5
Comorbid anxiety disorders in late-life depression: results of a cohort study.老年抑郁症中的共病焦虑障碍:一项队列研究的结果
Int Psychogeriatr. 2015 Jul;27(7):1157-65. doi: 10.1017/S1041610214002312. Epub 2014 Nov 5.
6
How significant is the assessment of the DSM-5 'anxious distress' specifier in patients with major depressive disorder without comorbid anxiety disorders in the continuation/maintenance phase?在持续性/维持性治疗阶段,对于没有共病焦虑障碍的重性抑郁障碍患者,评估 DSM-5“焦虑痛苦”特征的重要性如何?
Int J Psychiatry Clin Pract. 2021 Nov;25(4):385-392. doi: 10.1080/13651501.2021.1907415. Epub 2021 Apr 11.
7
Children of currently depressed mothers: a STAR*D ancillary study.当前患有抑郁症母亲的子女:一项STAR*D辅助研究。
J Clin Psychiatry. 2006 Jan;67(1):126-36. doi: 10.4088/jcp.v67n0119.
8
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder.DSM-5 焦虑痛苦特征对大样本重性抑郁障碍患者临床结局的纵向预测效度。
J Clin Psychiatry. 2017 Feb;78(2):207-213. doi: 10.4088/JCP.15m10221.
9
Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.重度抑郁症中的三维人格问卷因素:与焦虑症共病及发病年龄的关系。
Psychother Psychosom. 2005;74(3):173-8. doi: 10.1159/000084002.
10
Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.焦虑性痛苦可预测开始抗抑郁治疗的抑郁症患者随后的治疗结果及副作用。
J Psychiatr Res. 2017 Jan;84:41-48. doi: 10.1016/j.jpsychires.2016.09.018. Epub 2016 Sep 21.

引用本文的文献

1
Concurrent validity and reliability of the session rating of perceived exertion scale among high-trained rower during training sessions.训练期间高水平赛艇运动员自感用力度量表的同时效度和信度
BMC Sports Sci Med Rehabil. 2025 Jul 11;17(1):196. doi: 10.1186/s13102-025-01247-7.
2
High-definition transcranial direct current stimulation (HD-tDCS) in major depressive disorder with anxious distress-a study protocol for a double-blinded randomized sham-controlled trial.伴有焦虑苦恼的重性抑郁障碍的高清经颅直流电刺激(HD-tDCS)-一项双盲随机假刺激对照试验的研究方案。
Trials. 2024 May 15;25(1):320. doi: 10.1186/s13063-024-08157-y.
3
Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications.重度抑郁症患者的焦虑症状:关于患病率及临床意义的评论
Neurol Ther. 2023 Apr;12(Suppl 1):5-12. doi: 10.1007/s40120-023-00469-6. Epub 2023 Apr 28.
4
Anxiety Symptoms in Depression: Contemporary Treatment Approaches.抑郁症中的焦虑症状:当代治疗方法
Neurol Ther. 2023 Apr;12(Suppl 1):1-4. doi: 10.1007/s40120-023-00468-7. Epub 2023 Apr 28.
5
The Wistar Kyoto Rat: A Model of Depression Traits.Wistar Kyoto 大鼠:抑郁特征模型。
Curr Neuropharmacol. 2023;21(9):1884-1905. doi: 10.2174/1570159X21666221129120902.
6
Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence.藏红花及其活性成分对人类疾病的作用:关于现有临床证据的文献综述
Iran J Basic Med Sci. 2022 Aug;25(8):913-933. doi: 10.22038/IJBMS.2022.63378.13985.
7
Neural correlates of anxious distress in depression: A neuroimaging study of reactivity to emotional faces and resting-state functional connectivity.抑郁患者焦虑痛苦的神经相关因素:情绪面孔反应性和静息态功能连接的神经影像学研究。
Depress Anxiety. 2022 Jul;39(7):573-585. doi: 10.1002/da.23264. Epub 2022 May 10.
8
Association of Depression and Anxiety With the Accumulation of Chronic Conditions.抑郁和焦虑与慢性疾病积累的关联。
JAMA Netw Open. 2022 May 2;5(5):e229817. doi: 10.1001/jamanetworkopen.2022.9817.
9
Comparing the associations of three psychometric scales at baseline with long-term prognosis of depression over a 10-year period.比较三种心理计量学量表在基线时与 10 年内抑郁症长期预后的关联。
Int J Methods Psychiatr Res. 2022 Mar;31(1):e1896. doi: 10.1002/mpr.1896. Epub 2021 Oct 29.
10
Comorbid mental disorders, depression symptom severity, and role impairment among Veterans initiating depression treatment through the Veterans Health Administration.通过退伍军人健康管理局开始接受抑郁症治疗的退伍军人中的共病精神障碍、抑郁症状严重程度和角色功能损害。
J Affect Disord. 2021 Jul 1;290:227-236. doi: 10.1016/j.jad.2021.04.033. Epub 2021 Apr 27.

本文引用的文献

1
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.美国成人 DSM-5 重性抑郁障碍及其特征的流行病学。
JAMA Psychiatry. 2018 Apr 1;75(4):336-346. doi: 10.1001/jamapsychiatry.2017.4602.
2
Reliability and validity of the DSM-5 Anxious Distress Specifier Interview.《精神疾病诊断与统计手册》第五版焦虑痛苦特征访谈的信度与效度
Compr Psychiatry. 2017 Jul;76:11-17. doi: 10.1016/j.comppsych.2017.02.010. Epub 2017 Mar 2.
3
Psychometric Properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in Outpatients with Anxiety and Mood Disorders.广泛性焦虑障碍量表-7(GAD-7)在焦虑和情绪障碍门诊患者中的心理测量特性。
J Psychopathol Behav Assess. 2017 Mar;39(1):140-146. doi: 10.1007/s10862-016-9571-9. Epub 2016 Sep 10.
4
Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.焦虑性痛苦可预测开始抗抑郁治疗的抑郁症患者随后的治疗结果及副作用。
J Psychiatr Res. 2017 Jan;84:41-48. doi: 10.1016/j.jpsychires.2016.09.018. Epub 2016 Sep 21.
5
The prevalence and clinical characteristics associated with Diagnostic and Statistical Manual Version-5-defined anxious distress specifier in adults with major depressive disorder: results from the International Mood Disorders Collaborative Project.与《精神疾病诊断与统计手册》第5版定义的重度抑郁症成人患者中焦虑痛苦特征相关的患病率及临床特征:国际心境障碍协作项目的结果
Ther Adv Chronic Dis. 2016 May;7(3):153-9. doi: 10.1177/2040622315627805. Epub 2016 Feb 1.
6
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder.DSM-5 焦虑痛苦特征对大样本重性抑郁障碍患者临床结局的纵向预测效度。
J Clin Psychiatry. 2017 Feb;78(2):207-213. doi: 10.4088/JCP.15m10221.
7
A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.一种针对重度抑郁症的DSM-5焦虑痛苦特征的具有临床实用性的自我报告测量方法。
J Clin Psychiatry. 2014 Jun;75(6):601-7. doi: 10.4088/JCP.13m08961.
8
Defining anxious depression: a review of the literature.定义焦虑性抑郁:文献综述。
CNS Spectr. 2013 Oct;18(5):252-60. doi: 10.1017/S1092852913000114. Epub 2013 Mar 14.
9
The latent symptom structure of the Beck Depression Inventory-II in outpatients with major depression.贝克抑郁自评量表第二版在门诊重度抑郁症患者中的潜在症状结构。
Psychol Assess. 2010 Sep;22(3):603-8. doi: 10.1037/a0019698.
10
Specificity of autonomic arousal to DSM-IV panic disorder and posttraumatic stress disorder.自主唤醒对 DSM-IV 惊恐障碍和创伤后应激障碍的特异性。
Behav Res Ther. 2009 Jun;47(6):487-93. doi: 10.1016/j.brat.2009.02.016. Epub 2009 Mar 4.